Featured Research

from universities, journals, and other organizations

Study examines whether age for initial screening colonoscopy should be different for men, women

Date:
September 27, 2011
Source:
JAMA and Archives Journals
Summary:
An analysis of results of more than 40,000 screening colonoscopies finds that men have a higher rate of advanced tumors compared to women in all age groups examined, suggesting that the age that individuals should undergo an initial screening colonoscopy should be sex-specific, according to a new study.

An analysis of results of more than 40,000 screening colonoscopies finds that men have a higher rate of advanced tumors compared to women in all age groups examined, suggesting that the age that individuals should undergo an initial screening colonoscopy should be sex-specific, according to a study in the Sept. 28 issue of JAMA.

Although some studies have shown that men are at greater age-specific risk for advanced colorectal neoplasia than women, the age for referring patients to screening colonoscopy for colorectal cancer (CRC) in average-risk patients is 50 years for both men and women because of the increase in the prevalence of CRC in the sixth decade of life. The goal of screening colonoscopy is to find and remove adenomas (polyps, or benign tumors) and particularly advanced adenomas (AAs), according to background information in the article.

Monika Ferlitsch, M.D., of the Austrian Society for Gastroenterology and Hepatology, Vienna, Austria, and colleagues conducted a study to investigate the most appropriate age for initial screening colonoscopy for both male and female patient groups to achieve a higher detection rate of adenoma, AA, and CRC, which could result in a lower CRC mortality rate. The study included 44,350 participants in a national screening colonoscopy program over a 4-year period (2007 to 2010) in Austria. Of the participants, 51 percent were women; the median (midpoint) ages were 60.7 years for women and 60.6 years for men.

The results of the screening colonoscopies included polyps in 34.4 percent (n = 15,267) of the patients, colon cancer in 0.4 percent (n = 162), and rectal cancer in 0.2 percent (n = 92). In 61.4 percent (n = 27,212) of the colonoscopies, no abnormalities were found. Adenomas were found in 19.7 percent of individuals screened, AAs in 6.3 percent, and CRCs in 1.1 percent. The prevalence of adenomas was 24.9 percent for men and 14.8 percent for women; among 50- to 54-year-old men, the prevalence was 18.5 percent, which was greater than the prevalence among women in the same age group (10.7 percent) but similar to the prevalence among 65- to 69-year-old women (17.9 percent). The average number needed to screen (NNS) to detect adenomas were 5.1 for all individuals, 4.0 for men, and 6.7 for women. In 50- to 54-year-old women, NNS was nearly twice as high as in men at the same age (9.3 vs. 5.4). Among 45- to 49-year-old men, NNS was 5.9; a similar NNS of 6.0 was found for women ages 60 to 64 years.

"The prevalence of AAs in 50- to 54-year-old individuals was 5.0 percent in men but 2.9 percent in women; the NNS in men was 20 vs. 34 in women. There was no statistical significance between the prevalence and NNS of AAs in men aged 45 to 49 years compared with women aged 55 to 59 years (3.8 percent vs. 3.9 percent and 26.1 vs. 26," the authors write.

The prevalence of CRC was twice as high among men compared with women (1.5 percent vs. 0.7 percent). A prevalence of 1.2 percent among 65- to 69-year-old women was similar to that in 55-to 59-year-old men (1.3 percent). The researchers found that 55- to 59-year-old men had similar NNS for CRC to that for women who were 10 years older (65-69 years): 75.0 vs. 81.8, respectively.

"In our study, analysis of age- and sex-specific prevalence of adenomas, AAs, and CRC indicates a significantly higher rate of these lesions among men compared with women in all age groups, suggesting that male sex constitutes an independent risk factor for colorectal carcinoma and indicating new sex-specific age recommendations for screening colonoscopy," the authors write.

The researchers note that "deciding whether to adjust the age at which screening begins also requires considering whether the recommended age for women should be older or the recommended age for men younger."

"Further prospective studies are needed to demonstrate the relative clinical effectiveness of screening at different ages."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Monika Ferlitsch, Karoline Reinhart, Sibylle Pramhas, Caspar Wiener, Orsolya Gal, Christina Bannert, Michaela Hassler, Karin Kozbial, Daniela Dunkler, Michael Trauner, Werner Weiss. Sex-Specific Prevalence of Adenomas, Advanced Adenomas, and Colorectal Cancer in Individuals Undergoing Screening Colonoscopy. JAMA, 2011; 306 (12): 1352-1358 DOI: 10.1001/jama.2011.1362

Cite This Page:

JAMA and Archives Journals. "Study examines whether age for initial screening colonoscopy should be different for men, women." ScienceDaily. ScienceDaily, 27 September 2011. <www.sciencedaily.com/releases/2011/09/110927161647.htm>.
JAMA and Archives Journals. (2011, September 27). Study examines whether age for initial screening colonoscopy should be different for men, women. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/09/110927161647.htm
JAMA and Archives Journals. "Study examines whether age for initial screening colonoscopy should be different for men, women." ScienceDaily. www.sciencedaily.com/releases/2011/09/110927161647.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins